Zealand Pharma Profit Margin 2017-2021 | ZLDPF
Current and historical gross margin, operating margin and net profit margin for Zealand Pharma (ZLDPF) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Zealand Pharma net profit margin as of March 31, 2021 is -243.6%.
|Zealand Pharma Annual Profit Margins
|Zealand Pharma Quarterly Profit Margins
||Medical - Biomedical and Genetics
Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark.